USD 5.19
(-2.26%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 63.89 Million USD | -34.57% |
2022 | 97.65 Million USD | 63.49% |
2021 | 59.73 Million USD | 84.72% |
2020 | 32.33 Million USD | 142.5% |
2019 | 13.33 Million USD | 18.64% |
2018 | 11.23 Million USD | 55.88% |
2017 | 7.21 Million USD | 52.77% |
2016 | 4.71 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 39.29 Million USD | 0.0% |
2024 Q1 | 39.29 Million USD | -38.51% |
2023 FY | 63.89 Million USD | -34.57% |
2023 Q3 | 63.89 Million USD | -25.41% |
2023 Q4 | 63.89 Million USD | 0.0% |
2023 Q2 | 85.66 Million USD | 0.0% |
2023 Q1 | 85.66 Million USD | -12.27% |
2022 Q2 | 94.31 Million USD | 0.0% |
2022 Q4 | 97.65 Million USD | 0.0% |
2022 Q3 | 97.65 Million USD | 3.54% |
2021 Q2 | 63.6 Million USD | 0.0% |
2021 Q4 | 59.73 Million USD | 0.0% |
2020 Q4 | 32.33 Million USD | 0.0% |
2020 Q2 | 17.89 Million USD | 0.0% |
2019 Q4 | 13.33 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Accuray Incorporated | 468.62 Million USD | 86.365% |
Envoy Medical, Inc. | 7.64 Million USD | -736.335% |
Delcath Systems, Inc. | 38.61 Million USD | -65.478% |